| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |